Literature DB >> 10515310

Drug discrimination in neurobiology.

F C Colpaert1.   

Abstract

Areas of neurobiological interest are identified towards which drug discrimination (DD) studies have made important contributions. DD allows ligand actions to be analyzed at the whole organism level, with a neurobiological specificity that is exquisite and often unrivalled. DD analyses have thus been made of a vast array of CNS agents acting on receptors, enzymes, or ion channels, including most drugs of abuse. DD uniquely offers access to the study of subjective drug effects in animals, using a methodology that also is transposable to humans and has generated unprecedented models of pathology (e.g., chronic pain, opiate addiction). Parametric studies of such independent variables as training dose and reinforcement provide refined insights into the dynamic psychophysiological mechanisms of both drug effects and behavior. Three different mechanisms have been identified by which discriminative, and perhaps other behaviors, can come about. DD also is superbly sensitive to small, partial activation of molecular substrates; this has enabled DD analyses to pioneer the unravelling of molecular mechanisms of drug action (attributing, f.ex., LSD's particular subjective effects to an unusual, partial activation of 5-HT, and perhaps other receptors). DD has both oriented and served as a tool to conduct drug discovery research (e.g., pirenperone-risperidone, loperamide). The DD response arguably constitutes a quantal, rather than graded, variable, and as such allows a comprehension of molecular, pharmacological, and behavioral mechanisms that would have been otherwise inaccessible. Perhaps most important are the following further contributions. One is the notion that particular, different levels of receptor activation are associated with qualities of neurobiological actions that also differ and are unique, this notion arguably constituting the most significant addition to affinity and intrinsic activity since the earliest theoretical conceptions of molecular pharmacology. Another contribution consists of studies that render redundant the notion of tolerance and identify fundamental mechanisms of signal transduction; these mechanisms account for apparent tolerance, dependence, addiction, and sensitization, and appear to operate ubiquitously in a bewildering array of biological systems.

Entities:  

Mesh:

Year:  1999        PMID: 10515310     DOI: 10.1016/s0091-3057(99)00047-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  57 in total

1.  N-methyl-D-aspartate receptor channel blocker-like discriminative stimulus effects of nitrous oxide gas.

Authors:  Kellianne J Richardson; Keith L Shelton
Journal:  J Pharmacol Exp Ther       Date:  2014-11-03       Impact factor: 4.030

Review 2.  Neuropharmacology of the interoceptive stimulus properties of nicotine.

Authors:  Thomas E Wooters; Rick A Bevins; Michael T Bardo
Journal:  Curr Drug Abuse Rev       Date:  2009-09

Review 3.  Animal models of cannabinoid reward.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

4.  Differential cross-tolerance to the effects of nicotinic acetylcholine receptor drugs in C57BL/6J mice following chronic varenicline.

Authors:  Fernando B de Moura; Lance R McMahon
Journal:  Behav Pharmacol       Date:  2019-08       Impact factor: 2.293

5.  Mu opioid mediated discriminative-stimulus effects of tramadol: an individual subjects analysis.

Authors:  Justin C Strickland; Craig R Rush; William W Stoops
Journal:  J Exp Anal Behav       Date:  2015-02-09       Impact factor: 2.468

6.  Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.

Authors:  Marcello Solinas; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

7.  Effects of the GABAB receptor-positive modulators CGP7930 and rac-BHFF in baclofen- and γ-hydroxybutyrate-discriminating pigeons.

Authors:  Wouter Koek; Charles P France; Kejun Cheng; Kenner C Rice
Journal:  J Pharmacol Exp Ther       Date:  2012-02-07       Impact factor: 4.030

8.  Drug discrimination: 30 years of progress.

Authors:  Joseph H Porter; Adam J Prus
Journal:  Psychopharmacology (Berl)       Date:  2009-02-19       Impact factor: 4.530

9.  Benzodiazepine-like discriminative stimulus effects of toluene vapor.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  Eur J Pharmacol       Date:  2013-11-15       Impact factor: 4.432

10.  The impact of early environmental rearing condition on the discriminative stimulus effects and Fos expression induced by cocaine in adult male and female rats.

Authors:  Stephen J Kohut; Peter G Roma; Catherine M Davis; Gerald Zernig; Alois Saria; Juan M Dominguez; Kenner C Rice; Anthony L Riley
Journal:  Psychopharmacology (Berl)       Date:  2008-10-25       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.